USPTO serial 79339131
COVIRUPT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 4, 2023
- Examiner
- LE, KHANH M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COVIRUPT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alan M. Weisberg
Alan M. Weisberg CHRISTOPHER & WEISBERG, P.A.1232 N. University DriveChristopher & Weisberg, P.A.Plantation, FL 33322Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | biochemical and biological preparations and reagents for scientific use, other than for medical or veterinary purposes; biological preparations for industrial use, other than for medical or veterinary purposes; reagents for industrial research purposes, other than for medical or veterinary purposes; biochemical and biological preparations and reagents for research and development in the fields of human and veterinary medicine, pharmacy, biology and biotechnology; industrial detergents for use in manufacturing processes; detergents for use in industrial manufacturing processes; active biochemical and biological ingredients for use in the manufacture of pharmaceutical preparations for treating viruses; active biochemical and biological additives for use in the manufacture of medical dressings; biochemical and biological additives for use in the manufacture of medicine, pharmaceutical preparations, medical dressings and plasters, personal care products and sanitary products; biochemical and biological additives and active biochemical and biological ingredients for use in the manufacture of medicines and pharmaceuticals for treating viral infections, medical dressings and plasters, personal care products and sanitary products; biochemical and biological preparations, for use in the manufacture of pharmaceuticals for treating viral infections; biochemical and biological raw materials for use as active ingredients in the manufacture of pharmaceutical preparations for treating viral infections; biochemical and biological preparations having antimicrobial and/or virucidal properties for scientific research purposes and other than for medical or veterinary purposes; biological, biochemical and biotechnological substances for use as additives in the manufacture of personal care products | ACTIVE | — |
| 005 | Medicines for the treatment of viral infections; pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations in the form of aqueous solution, inhalation solution, and injectable solutions for use in the treatment of viral infections; pharmaceuticals in the form of medicated creams, lotions, and ointments for dermatological use; preparations against infectious agents, namely, disinfectants; sanitary preparations for medical and veterinary purposes; medicated virucidal mouth and throat washes; medicated products for the treatment of viral infections, namely, mouth and throat sprays, nasal sprays, nasal oils, nasal ointments, nasal creams and nasal drops for medical and veterinary purposes; medicated lozenges for medical purposes; skin disinfectant; medicated skin care preparations; antiseptic wipes for medical, veterinary and surgical purposes; disinfectants; wipes and medical dressings impregnated with disinfectants or virucidal pharmaceutical solutions; disinfecting biochemical and biological preparations for medical and veterinary purposes; virucides for medical or veterinary purposes; polypeptides, nucleic acids, proteins, lipids, enzymes and enzyme preparations for medical, veterinary and disinfection purposes; medicated eye washes, medicated eye drops and additives for medicated eye washes and medicated eye drops; animal feed additives for treating infectious diseases; germicides; cleansing preparations with disinfecting effect for hygienic purposes; medicated animal and livestock washes | ACTIVE | — |
| 042 | Scientific research in the field of pharmaceuticals; research and development services and research work in the fields of medicine, pharmacy, bacteriology, virology, health products, cosmetics and food supplements; research and development consultancy, in particular in the fields of medicine, pharmacy, bacteriology, virology, health products, cosmetics and food supplements; industrial analytical and research services, in particular in the fields of antimicrobial and virucidal analysis and research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Lysando AG
- Other trademarks owned by Lysando AG
- Other trademarks owned by Lysando AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named COVIRUPT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 31, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 6, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 6, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 4, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 4, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 25, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 18, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 18, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 5, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 5, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 4, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 11, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 11, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 11, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 15, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 14, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 6, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 15, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 15, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 18, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 17, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 29, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 28, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |